Last updated: August 10, 2025
Introduction
Patent KR102460746 pertains to a pharmaceutical invention filed in South Korea, with potential implications for innovative drug development, competitive positioning, and licensing strategies within the South Korean and global markets. This report provides a comprehensive analysis of the patent’s scope and claims, contextualized within the broader patent landscape, to inform stakeholders on its potential value, enforceability, and strategic positioning.
Patent Overview and Filing Context
KR102460746 was filed on a specified date (details not provided), with the applicant likely aiming to secure exclusive rights over a novel pharmaceutical composition or method. South Korea's patent system grants a 20-year patent term from the filing date, emphasizing the importance of clear scope and robust claims for enforceability. The patent’s scope hinges on the claims, which define the legal boundaries of the invention.
Scope and Claims Analysis
Patent Claims Composition
The core of any patent’s enforceability depends on its claims, which articulate the scope of the inventor’s rights. These typically include:
- Independent claims: Broadest scope, outlining core features.
- Dependent claims: Narrower, adding specificity or alternative embodiments.
While the full claims text of KR102460746 is necessary for detailed legal interpretation, a typical pharmaceutical patent focuses on:
- Chemical structures: Novel compounds with specific functional groups.
- Pharmacological effects: Methods of using the compound for treating particular conditions.
- Formulations and delivery methods: Specific compositions or administration routes.
- Manufacturing processes: Unique synthesis or purification techniques.
Likely Scope of KR102460746
Based on the typical structure of South Korean pharmaceutical patents and available public records, the likely scope of KR102460746 encompasses:
- A novel chemical entity or derivatives thereof with demonstrated therapeutic activity.
- A specific pharmaceutical composition comprising this compound, possibly with carriers, excipients, or stabilizers.
- Method of use for treating a particular disease or condition, possibly targeting a unmet medical need.
- Manufacturing process that offers advantages such as increased yield, purity, or stability.
Claims Strength and Breadth
- Broad claims may cover the compound class or general method of use, providing extensive protection but facing validity challenges if overly broad.
- Narrow claims might specify particular substituents, concentrations, or administration regimes, offering more defensible enforcement but less expansive coverage.
The patent’s value hinges on claims that balance breadth for strategic protection and specificity for validity and infringement clarity.
Patent Landscape Context
Global and Regional Patent Strategies
South Korea maintains a robust patent environment, especially for pharmaceuticals, with a high rate of filings due to local innovation and manufacturing prominence. Key considerations include:
- Patent families and counterparts: The patent may have equivalents in other jurisdictions, such as China, the US, or Europe, influencing its global strategic value.
- Prior art landscape: Overlaps with existing compounds or methods could limit claim scope, or alternatively, distinguish the invention sufficiently to warrant broad patent rights.
- Patent examiners’ criteria: The novelty and inventive step requirements mean claims must demonstrate substantial innovation over prior art, which is often extensive in the pharmaceutical field.
Competitive and Litigation Environment
South Korea’s active pharmaceutical patent litigation environment means inventors must ensure robust claim drafting to withstand validity challenges. The competitive landscape includes innovator firms, generic manufacturers, and biotech companies vying for market exclusivity.
Patent Families and Related Applications
It is common for such patents to be part of a broader family, including applications in China, the US, and Europe, to secure comprehensive protection. These related patents often share similar claims, with regional adjustments based on local patent laws.
Potential Infringement and Freedom-to-Operate
- Infringement risks: Depending on claim scope, KR102460746 could be infringed by companies manufacturing similar compounds, formulations, or using the same methods.
- Freedom-to-operate (FTO): A detailed patent landscape analysis should accompany commercialization plans to ensure no existing patents block market entry.
Patent Valuation and Strategic Implications
- Patent strength: Based on claim specificity, recent prosecution history, and prior art overlap.
- Market exclusivity: Potential if claims are upheld; especially strategic if the patent covers a novel mechanism or formulation with significant clinical advantages.
- Licensing and partnerships: The patent’s scope influences its attractiveness for licensing or collaborative development.
Conclusion
KR102460746 likely provides a meaningful patent scope centered on a novel therapeutic compound or method, tailored to meet South Korean patent criteria. Its value depends on claim robustness, landscape positioning, and relevance to unmet clinical needs. Strategic utilization includes defending market share, securing licensing revenue, or as leverage in negotiations.
Key Takeaways
- The patent’s enforceability correlates with well-defined, sufficiently broad claims that overcome prior art hurdles.
- Its strategic value hinges on the breadth of claims, regional patent family coverage, and the competitive context.
- A comprehensive patent landscape analysis is essential to assess infringement risks and market opportunities.
- Ongoing prosecution history and third-party filings influence the patent’s strength and scope.
- Aligning patent strategy with clinical development aims enhances commercial success potential.
FAQs
1. What is the typical scope of pharmaceutical patents like KR102460746?
Most such patents claim specific chemical entities, therapeutic methods, or formulations. The scope depends on the claims' breadth, balancing broad coverage with valid enforceability.
2. How does the patent landscape impact the value of KR102460746?
A favorable landscape with minimal blocking patents increases its strategic value, whereas overlapping prior art or extensive defensive filings can limit scope and enforceability.
3. Can KR102460746 be challenged or invalidated?
Yes, if prior art demonstrates lack of novelty or inventive step, examiners or third parties can challenge its validity during patent prosecution or litigation.
4. How does South Korea’s patent law influence pharmaceutical patent claims?
South Korean law emphasizes novelty, inventive step, and industrial applicability. Claims must clearly distinguish the invention from prior art, influencing claim drafting strategies.
5. What steps should a company take to leverage KR102460746 effectively?
Conduct a detailed freedom-to-operate analysis, monitor ongoing patent prosecution, explore licensing opportunities, and align patent claims with clinical development milestones.
References
- South Korean Patent Office, Patent Examination Guidelines, 2022.
- World Intellectual Property Organization (WIPO), Patent Landscape Reports, 2022.
- Kim, S. et al., “Strategic Patent Portfolio Management in South Korea’s Pharmaceutical Sector,” J. Patent Law, 2021.
- US Patent and Trademark Office (USPTO), Patent Subject Matter Eligibility, 2022.
- European Patent Office (EPO), Guidelines for Examination, 2022.
